Ovarian Cancer: Leslie's Survivor Story

Patient Info: Leslie Medley-Russell, female

Biomarkers: CA-125 elevated at recurrence

After treatment for the January 2017 recurrence, she had no evidence of disease at the time of the story.

MD AndersonRead more →

Ovarian Cancer With Severe Dermatomyositis During Treatment

Patient Info: Anonymized, female, 60s | Stage III

Biomarkers: BRCA1 mutation

She continued paclitaxel and carboplatin while being treated for severe dermatomyositis and later described herself as finally on the mend.

PubMed CentralRead more →

High-Grade Serous Ovarian Cancer With a Paraneoplastic Skin Condition

Patient Info: Anonymized, female, 60s

During first-line carboplatin and paclitaxel chemotherapy, the paraneoplastic skin changes regressed and the CA125 level returned to the normal range.

PubMed CentralRead more →

Ovarian Cancer Recurrence Complicated by a Benign Surgical Stitch Reaction

Patient Info: Anonymized, female, 40s | Stage III

Diffuse peritoneal relapse was confirmed, and she remained on third-line chemotherapy with persistent evidence of ovarian cancer.

PubMed CentralRead more →

Stage III BRCA1 Ovarian Cancer: Meredith's Survivor Story

Patient Info: Meredith Ippolito, female | Stage III

Biomarkers: BRCA1 mutation

Meredith was told she was cancer-free in April 2009 and continued follow-up visits every 6 months.

MD AndersonRead more →

Stage IV Ovarian Cancer: Bre's Patient Story

Patient Info: Bre Tipps, female, Under 40 | Stage IV

A recent CT scan showed the remaining tumors calcifying and dying during hormonal therapy, although the patient expected to need ongoing ovarian cancer treatment.

MD AndersonRead more →

Ovarian Granulosa Cell Tumor Recurs 22 Years After Initial Surgery

Patient Info: Anonymized, female, 60s

A metastatic granulosa cell tumor recurrence was confirmed 22 years after her original surgery and was treated with maximal debulking surgery.

PubMed CentralRead more →

Recurrent Stage III Ovarian Cancer in a BRCA1 Carrier Treated With Multiple Therapies

Patient Info: Anonymized, female, 40s | Stage III

Biomarkers: BRCA1 mutation

By late 2011, hilar nodal disease was slowly progressing and bevacizumab was started for the recurrent ovarian cancer.

PubMed CentralRead more →

Recurrent Stage III Ovarian Cancer Complicated by Severe Kidney Injury

Patient Info: Anonymized, female, 70+ | Stage III

After further intra-abdominal cancer progression and severe kidney injury, she developed seizures, encephalopathy, and limb ischemia and died 1 week after hospitalization in May 2011.

PubMed CentralRead more →

Recurrent Ovarian Cancer With Severe Kidney Injury During Long-Term Treatment

Patient Info: Anonymized, female, 60s

Despite severe chronic kidney disease, later chemotherapy produced some regression of the progressing ovarian cancer with each sequential regimen.

PubMed CentralRead more →

Stage III Ovarian Cancer in a BRCA1 Carrier Treated With Long-Term Maintenance Therapy

Patient Info: Anonymized, 50s | Stage III

Biomarkers: BRCA1 mutation

After long-term maintenance therapy, she had no evidence of ovarian cancer at the latest follow-up.

PubMed CentralRead more →

Recurrent Stage III Ovarian Cancer in a BRCA2 Carrier Treated Over Many Years

Patient Info: Anonymized, 40s | Stage III

Biomarkers: BRCA2 mutation

She later developed a separate aggressive oral squamous cell carcinoma and died in 2011 from acute airway obstruction during progression of that cancer.

PubMed CentralRead more →

Stage III Ovarian Cancer in a BRCA1 Carrier With Long-Term Disease Control

Patient Info: Anonymized, 60s | Stage III

Biomarkers: BRCA1 mutation

At the latest follow-up in January 2012, she had no recurrence of ovarian cancer and was well.

PubMed CentralRead more →